We are delighted to announce that HIV-DART and Respi-DART 2024 will be held at the Hacienda del Mar, Los Cabos, Mexico from December 1 to 5, 2024.

14 total CME AMA PRA Category 1 Credit Hours

Talks from Key Opinion Leaders from Around the World

No Concurrent Sessions

20 Opportunities for Oral Abstract Presentations

2 Poster Sessions

Networking Opportunities

Registration Now Open!

Registration Includes:

  • Access to all session

  • Opening Reception- December 1, 2024

  • Poster Reception- December 2, 2024

  • Poster Reception- December 4, 2024

  • Breakfast- December 2-5, 2024

  • Lunch December 2-4, 2024

  • Closing Reception- December 4, 2024

 
 

Registration Includes:

  • Access to all session- December 3rd at 3pm- December 5th, 2024

  • Poster Reception- December 4, 2024

  • Breakfast- December 4-5, 2024

  • Lunch December 4-5, 2024

  • Closing Reception- December 4, 2024

Registration Includes:

  • Access to all sessions- December 1-December 3rd at 1 pm.

  • Opening Reception- December 1, 2024

  • Poster Reception- December 2, 2024

  • Breakfast- December 2-3, 2024

  • Lunch December 2-3, 2024

HIV-DART Invited Academic Speakers

More Speakers Exciting Announced Soon!

 
 
 
 

Respi-DART Invited Academic Speakers

More Speakers Exciting Announced Soon!

 
 

DART series conferences were first launched in 1995 to address unmet needs in antiviral drug therapeutics and vaccine development for important viral diseases such as HIV, hepatitis C and hepatitis B. Over the years, DART conferences have evolved to reflect the fast-paced and ever-changing landscape of global disease burdens, new therapeutic strategies and access to care. HIV-DART 2024 will bring a sharp focus on strategies for HIV cure, and advances in long-acting formulations. The meeting will also focus on new advances in treatment against emerging diseases such as dengue, chikungunya, yellow fever and zika.

In 2018, Respi-DART was added to the DART meeting series in response to a growing need to face the challenges imposed by respiratory diseases such as RSV, influenza, and most recently SARS-CoV-2.

HIV-DART and Respi-DART are scheduled to take place back-to-back with registration discounts available to delegates who are interested in participating in both meetings. The meetings are scheduled to take place in-person.

Please stay tuned for more announcements regarding the scientific program, registration and additional pertinent details.


Informed Horizons Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. and will award AMA PRA Category 1 CreditTM to physicians who complete this program. In the development and presentation of the program, Informed Horizons Education, Inc. will adhere to all rules, regulations and guidelines of the ACCME, AMA, AAMC, FDA and OIG that govern the conduct of accredited CME activities. All scientific materials presented will be objective and show fair balance as to the range of diagnostic and therapeutic modalities.

  • Register for HIV & Respi DART 2024 HERE

  • Check out the 2024 scientific program overview HERE (coming soom)

  • Learn about the conference venue HERE

  • Learn about HIV & Respi-DART 2024 abstract opportunities HERE

  • Learn about HIV & Respi-DART 2024 sponsorship opportunities HERE


Informed Horizons Education, Inc. (IHE), a non-profit medical education company, will serve as conference secretariat for HIV-DART 2024 & Respi-DART 2024 conferences. For more information, contact us at info@ihorizonsed.com.